3 Under-the-Radar Stocks Flying Completely Under the Radar While Everyone Fights About Oil

While the financial media collectively loses its mind over the Strait of Hormuz and whether JD Vance can close a deal in Islamabad, a Bloomberg Money Minute buried a genuinely interesting tidbit: CommVault Systems ($CVLT) is reportedly exploring a sale after drawing interest from multiple potential acquirers. The data management software company — which most people couldn't pick out of a lineup — surged over 10% on the Reuters report. With cloud data protection becoming table stakes in an era where Anthropic's AI is reportedly finding decade-old vulnerabilities in every major OS and browser, CVLT's niche looks a lot more strategic. A takeout here isn't a stretch.

Next up: H.B. Fuller ($FUL), a specialty adhesives company that almost nobody talks about — which is exactly why it's interesting. As fertilizer costs rise 10-15% through the energy shock supply chain and industrial input costs ripple outward, specialty chemical companies with pricing power become quietly valuable. FUL operates in a boring-but-defensible niche with global manufacturing exposure and has historically compounded well through inflationary cycles. Low profile, real business.

Finally, Procept BioRobotics ($PRCT) — a robotic surgical system maker focused on benign prostatic hyperplasia. No, not sexy. Yes, potentially very lucrative. The robotic surgery space is underpenetrated outside of Intuitive Surgical's monopoly, and PRCT is carving out a real foothold in urological procedures with its Aquablation system. With healthcare M&A heating up (see: Sun Pharma's rumored $12B run at Organon), smaller medtech names with proprietary platforms are prime targets. Sometimes the most interesting stocks are the ones CNBC forgets to mention.